MDM2 and cervical carcinoma: Al-Harbi et al., (2017) in a study among 232 cervical cancer cases and 313 control subjects evaluated the association of CDKN1A C31A, ATM G1853A, HDM2 T309G, TGFB1 T10C, XRCC1 G399A, and XRCC3 C241T with cervical cancer among Saudi Arabian women.